| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |